Ticagrelor | T0179

(No reviews yet) Write a Review
€174.00 - €318.00
SKU:
TMC-T0179
Availability:
IN STOCK
Adding to cart… The item has been added

Product Overview

Ticagrelor | T0179 | TargetMol Chemicals

CAS: 274693-27-5

Smiles: CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1

Formula: C23H28F2N6O4S

Pathway: Metabolism|||Neuroscience

Target: P450|||P2 Receptor

Receptor: N/A

Bioactivity: Ticagrelor, produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique(EU) and Possia(EU).

Molecular Weight: 522, 57

Reviews

(No reviews yet) Write a Review